Quantamental Technologies LLC Ultragenyx Pharmaceutical Inc. Transaction History

Quantamental Technologies LLC

  • $105 Million
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$33.72 - $46.33 $300,613 - $413,031
8,915 New
8,915 $413,000
Q3 2020

Nov 16, 2020
SELL
$72.98 - $90.0 $249,591 - $307,800
-3,420 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$46.91 - $78.22 $160,432 - $267,512
3,420 New
3,420 $268,000
Q4 2019

Feb 14, 2020
SELL
$36.08 - $45.83 $231,381 - $293,907
-6,413 Closed
0 $0
Q3 2019

Nov 08, 2019
BUY
$42.5 - $63.11 $272,552 - $404,724
6,413 New
6,413 $274,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.5M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.01B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email